Well many Aussie small cap funds are aware of it already thanks...

Well many Aussie small cap funds are aware of it already thanks to when it was Ellex Medical. They'd almost certainly be waiting for confirmation of sustained high sales growth in the US and a sustained improvement in the bottom line, but this report should provide that confirmation (a quick bump in order volumes from existing account would only be sustained for about one half, growth via new accounts would be needed to sustain growth for longer). They'll likely be forced to push it up to 50c and higher to free up liquidity and get a meaningful position, but even then it would still be looking quite cheap so I don't think they'd have too much of a problem with doing that.

We've observed via industry news, conference and training course presence and linkedin activity this sustained strong growth to be occurring, now time for the hard numbers to confirm what we've been seeing. Just a waiting game now imo